USA – How doctors will handle abortions if mifepristone telehealth access is banned

One in four abortions in the U.S. rely on telehealth access to mifepristone, but antiabortion activists want to ban it

May 27, 2026
By Meghan Bartels, edited by Tanya Lewis

After a tense few weeks during which U.S. courts twice revoked and reinstated telehealth access to the abortion pill mifepristone, the drug remains available without an in-office appointment—for now. But doctors and policy experts worry that uncertainty and any future rollback in access will make things harder for people seeking to end a pregnancy and place added pressure on the health care system.

Since 2022, when the Supreme Court’s ruling in Dobbs v. Jackson Women’s Health Organization overturned the right to abortion enshrined in Roe v. Wade, antiabortion proponents have focused on mifepristone. They claim, despite a wealth of evidence to the contrary, that the drug is unsafe. First approved in the U.S. in 2000, mifepristone is currently used here in combination with the drug misoprostol up to 10 weeks into a pregnancy.

Continued: https://www.scientificamerican.com/article/how-doctors-will-handle-abortions-if-mifepristone-telehealth-access-is-banned/


Above and Beyond Restoring Roe

Abortion rights aren’t enough. The best reproductive care outcomes result from meeting basic needs.

By Jade Prévost-Manuel
Mar 5, 2025

Taylor Young has never wanted to be a mom. From the time the now 27-year-old began dating, she experienced persistent anxiety around the thought of getting pregnant in Ohio, a Republican-controlled state where Young felt her right to abortion was tenuous.

In 2018, she discovered the childfree subreddit, an online forum on Reddit for people who do not have children and do not want them. In that forum, she learned about bilateral salpingectomy, a procedure that removes both fallopian tubes and permanently prevents pregnancy.

Continued: https://www.yesmagazine.org/body-politics/2025/03/05/progress-2025-beyond-roe


USA – Yes, some medication abortion patients go to the ER — but it may not be for what you think

A small portion of patients do visit ERs after an abortion, but it's not because mifepristone is unsafe

By NICOLE KARLIS
MARCH 20, 2024

Next Tuesday, the U.S. Supreme Court will finally hear a case about mifepristone — the first drug used in a medication abortion.

A ruling in favor of the plaintiffs, Alliance for Hippocratic Medicine — an organization of anti-abortion activists backed by the Christian right-wing lobbying group Alliance Defending Freedom — could severely limit access to mifepristone across the country. As women’s health specialists and doctors have told Salon before, the effects of such restrictions will be "devastating,” and have far-reaching consequences beyond impacting reproductive health.

Continued: https://www.salon.com/2024/03/20/yes-some-medication-abortion-patients-go-to-the-er--but-it-may-not-be-for-what-you-think/


A Trump-Stacked Court Hopes to Limit Access to the Abortion Pill. The Final Decision Now Lies With SCOTUS.

8/17/2023
by CARRIE N. BAKER, Ms. Magazine

The Fifth Circuit Court of Appeals released a decision on Wednesday, Aug. 16, that dismissed a challenge to the U.S. Food and Drug Administration’s 2000 approval of mifepristone, but would sharply restrict access to medication abortion nationwide and eliminate telemedicine abortion. The decision in Alliance for Hippocratic Medicine v. FDA remains on hold until final review by the U.S. Supreme Court.

“While the court has acknowledged that mifepristone—both brand and generic versions—can stay on the market, they are insisting we should roll back the clock to 2000 and put the medication under lock and key,” said Kirsten Moore, director of Expanding Medication Abortion Access Project (EMAA Project). “The extremist judges ignored the FDA, our basic rights, and more than 20 years of scientific evidence showing mifepristone is safe and effective, rolling back decades of advancement in the standard of care. This is a dangerous precedent for FDA’s scientific review authority.”

Continued: https://msmagazine.com/2023/08/17/abortion-pills-fifth-circuit-mifepristone/


USA – Why an ulcer drug could be the last option for many abortion patients

February 24, 2023
Sarah McCammon
3-Minute Listen with Transcript

A federal judge in Texas could rule as soon as today on whether to cut off access to a key medication abortion protocol, giving lawyers until day's end to submit additional arguments. Fearing another major blow to abortion access, some providers are already considering alternatives.

At the Trust Women clinic in Wichita, Kansas, it's already been crisis mode for months. And now clinic Director Ashley Brink says the staff is bracing for another — maybe even bigger — wave of uncertainty.

Continued: https://www.npr.org/2023/02/24/1159075709/abortion-drug-mifepristone-misoprotol-texas-case